Pfizer Vaccine Gets FDA Approval for COVID-19
Emergency authorization was provided to Pfizer's Covid-19 vaccine on Friday. The authorization of the vaccine has been highly anticipated.
Emergency authorization was provided to Pfizer’s Covid-19 vaccine on Friday.
The authorization of the vaccine has been highly anticipated.
The company plans to manufacture upwards of 50 million doses to be distributed globally by the end of the year with ambitions of having 1 billion doses distributed by the end of 2021.
Gen. Gustave F. Perna, the chief operating officer for the government vaccine program Operation Warp Speed, General Gustave F. Perna, stated during a briefing Saturday that vaccines will be delivered to the first administration sites on Monday.
Health-care workers and vulnerable seniors residing in long-term care facilities are slated to be the first inline to receive the vaccine.
Director of the FDA’s Center for Biologics Evaluation & Research Dr. Peter Marks said in a statement, “While not an FDA approval, today’s emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine hold the promise to alter the course of this pandemic in the United States.“
President Donald Trump touted to approval as “one of the greatest scientific accomplishments in history” in a video address.
In the video presentation, the president claimed that the vaccine “will save millions of lives, and soon end the pandemic, once and for all.“
© 2022 Enfield Media Group LLC - All Rights Reserved.